Zhejiang Starry Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is IOPAMIDOL, with a corresponding US DMF Number 28033.
Remarkably, this DMF maintains an Active status since its submission on December 23, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 11, 2016, and payment made on June 06, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II